Nationally, the CDC estimates that of the approximately 1 million persons in the United States who are infected with HIV, some 252,000-312,000, are unaware of their infection (Glynn & Rhodes, 2005) . A number of factors have been associated with late HIV diagnosis, including misperception of risks for HIV infection by providers and/or patients, patients' fear of receiving a positive HIV diagnosis, and providers' perceptions that requirements for HIV consent and counseling are too time consuming (CDC, 2003; Jenkins, Gardner, Thrun, Cohn, & Berman, 2006; Klein, Hurley, Merrill, & Quesenberry, 2003) .
As the largest integrated health care system in the United States (Oliver, 2007) , the Veterans Health Administration (VHA) is the biggest provider of HIV care in the United States. In fiscal year 2006, VHA provided care to nearly 23,000 HIV-infected veterans Veterans With HIV-AIDS, in VA Care, 2007) . Although widely recognized as an efficient and high-performing health care system (Asch et al., 2004; Jha, Perlin, Kizer, & Dudley, 2003) , late diagnosis of HIV infection has also been identified among veteran populations. In a retrospective chart review of four large Veterans Administration (VA) medical centers, Owens and his colleagues (2007) documented that only 36% of 13,991 veterans at risk for HIV had been tested for the virus (12). More telling still, Gandhi, Skanderson, Gordon, Concato, and Justice (2006) and his colleagues reported that among 3760 HAART-naïve patients newly presenting for HIV care at VA medical centers during 1998-2002, 55% had immunologic AIDS at the time of presentation. And Holodniy and his colleagues (2007) opined that "delayed identification of HIV infection" was responsible for a "substantial number" of HIV-infected veterans starting antiretroviral treatment below recommended CD4+ cell count thresholds.
Within the U.S. Department of Veterans Affairs, the Public Health Strategic Health Care Group (PHSHG) is responsible for promoting population health and clinical preventive services, including early HIV diagnosis and referral into care, for over 5 million veterans who receive care in VA health facilities. As part of an ongoing effort to encourage early diagnosis of HIV infection, a national survey of VA clinical laboratories was undertaken in early 2007, to determine the frequency of HIV diagnostic testing during a 1-year period across the entire VA system.
METHODS
A brief electronic survey was jointly developed by PHSHG and the Pathology and Laboratory Medicine Service (P&LMS), Office of Patient Services, at the VHA. The purpose of the survey was to collect baseline information on the volume and location of HIV screening, HIV confirmatory testing, rapid HIV testing-including point of care rapid testing-and practices related to informed consent. Prior to widespread dissemination, the survey was pilot-tested among a group of four VA clinical laboratory directors and revised based on their feedback. Following standard operating procedures, the survey was distributed electronically, in early January 2007, to chief and assistant chief medical officers at each of the 21 VA regional jurisdictions (known as Veterans Integrated Service Networks, or VISNs) with the instructions that the survey be forwarded to all clinical laboratory directors. Follow-up e-mail reminders were sent to nonresponsive laboratories during the month of February 2007.
RESULTS
Completed surveys were received from 135 VA laboratories. At present, the VA does not have a uniform reporting structure for clinical laboratories at a national level; furthermore, some facilities combine data, including point-of-care testing, and report as a single entity. Therefore, the denominator of all clinical laboratories across the VA system can vary between 150 and 171, depending upon whether test volumes are bundled prior to reporting. Although we cannot provide an exact response rate, we estimate that approximately 90% of all VA clinical laboratories responded to the survey.
The 135 laboratories that responded reported providing 112,033 HIV screening tests between October 1, 2005 , and September 30, 2006 (fiscal year 2006 . The total number of HIV screening tests was significantly greater in outpatients (81%) compared with inpatients (19%) (p < .0001, two-tailed t test), reflecting patient distribution ( Table 1 ). The total positive tests (n = 1,669) were also significantly greater in outpatients (80%) compared with inpatients (20%) (p < .003). The overall rate of confirmed HIV seropositive tests was 1.49%, with inpatients having a slightly higher seropositivity rate compared with outpatients (1.62% vs. 1.46%, p = N.S.). When analyzed by VISN, combined inpatient and outpatient prevalence ranged from 0.2% to 3.8%, inpatient prevalence ranged from 0.3% to 4.37% and outpatient prevalence ranged from 0.2% to 3.98% (see Table 1 ). In general, prevalence rates by VISN reflected the number of HIV-infected veterans in care in that VISN.
Forty-three percent (58/135) of laboratories reported performing HIV screening tests in-house, 32% (43/135) at another VA laboratory, 21% (28/135) at a commercial laboratory and 4% (6/135) "other." Fewer HIV confirmatory tests were performed "in house" (8%, or 11/135), with the majority of confirmatory tests being performed by commercial laboratories (51%, or 69/135) or another VA laboratory (33% or 45/135); 7% (10/135) reported that confirmatory HIV tests were performed by "other" laboratories.
When asked about rapid HIV testing, 67% (90/135) of reporting laboratories indicated that they had rapid HIV testing available within their facilities. In response to a follow-up question, most rapid HIV testing in the VA system appears to be taking place within the laboratory, rather than as point-of-care testing; over 60% of all rapid-test locations cited were "laboratory." The next most frequently cited locations were emergency departments (11% of locations cited) and employee health clinics (11% of locations cited). Primary care clinics, mental health clinics, substance abuse clinics, and other outpatient locales were less frequently cited.
Finally, respondents were asked, "Does your laboratory require a copy of the consent form prior to HIV testing?" Sixty-four percent of the respondents (87/135) indicated that the laboratory required a copy of the HIV testing consent form-or some other tangible proof that consent had been obtained-prior to testing. Despite clear policy directives encouraging routine HIV testing among U.S. veterans, substantial evidence exists that HIV testing is underutilized throughout the VA system . Although the VHA has a well-documented track record of high-quality medical care, strongly associated with proactive clinical performance measurement (Asch et al., 2004) , routine HIV testing is not a specified performance measure in the VA system. Gifford and colleagues (2006) identified nearly 271,000 veteran patients at increased risk for HIV infection (based on documented diagnoses of hepatitis B, hepatitis C, sexually transmitted infection, or substance abuse) of whom only 21% had been tested for HIV. Among nearly 12,000 veteran patients from the Pacific Northwest who were infected with hepatitis C virus, only a third (35%) had been tested for HIV (Huckans, Blackwell, Harms, Indest, & Hauser, 2005) .
Among the documented barriers to HIV testing in the VA health system are "lack of provider prioritization of HIV testing and the time needed for pre and post-test counseling" (Goetz et al., 2006) . At present, a 1988 federal law (section 124 of Public Law 100-322) requires written informed consent for HIV testing, documented in the veteran's medical record (Department of Veterans Affairs Information, 2006) . Many VA providers have stated that the requirement to obtain written informed consent is an impediment, given the multiple time demands on primary care providers (personal communications). Heightened awareness of the federal requirement for written informed consent among veteran patients can be seen in the widespread laboratory practice of requiring a copy of the HIV testing consent form, or some comparable documentation, before the laboratory will actually test the specimen (64% of surveyed laboratories).
Because of the current lack of a uniform reporting structure for VA clinical laboratories at a national level, it is not possible to calculate exact rates of HIV testing across the entire VA system. However, it is possible to develop functional estimates. In FY 2006 the VA recorded 5,537,839 unique outpatients and 368,585 unique inpatients (Dr. L. Mole, personal communication, March 19, 2007) . During this same time period, clinical laboratories reported performing 91,189 HIV screening tests on outpatients and 20,844 HIV screening tests on inpatients. Although a crude estimate with a number of caveats (e.g., not every laboratory responded to survey, the current lab survey tallied tests and not unique patients who had been tested, reported lab figures include duplicate tests, survey did not determine or account for previously tested veterans, etc.), one can reasonably assert that fewer than 5% of VA outpatients (91,189/5,367,774 = .0170 ) and fewer than 10 percent of VA inpatients (20,844/368,585 = .056) were tested for HIV in fiscal year 2006.
The overall seroprevalence of HIV infection in VA of those tested in this survey was 1.49% (VISN range = 0.2-3.8%). This prevalence rate is consistent with data from a recent blinded HIV seroprevalence study in six VA medical centers where the total prevalence was 3.7%, with a prevalence of previously undocumented HIV infection ranging from 0.1% to 2.8% among outpatients and from 0% to 1.7% among inpatients . In that study, HIV infection was significantly more likely to be present in VA outpatients and those veterans who were younger and Black. Current CDC recommendations suggest that routine universal HIV screening should be performed if the known seroprevalence in the population is > 0.1% (CDC, 2006) . Given the HIV seroprevalence found in this and other VA studies, the VA would benefit from a universal HIV testing policy.
Revised CDC HIV testing guidelines, released in September 2006, recommend that in health care settings, screening for HIV infection should be performed routinely for all patients aged 13-64 years of age (CDC, 2006) . Although the CDC stresses that screening should be voluntary and undertaken only with "the patient's knowledge and understanding that HIV testing is planned," the CDC no longer recommends a separate consent form for HIV testing (CDC, 2006, p. 7) . Instead, the September 2006 guidelines recommend that "consent for HIV screening should be incorporated into the patient's general informed consent for medical care on the same basis as are other screening or diagnostic tests (CDC, 2006, p. 8) . The guidelines recommend that patients should be informed orally or in writing that HIV testing will be performed, unless they decline. This is known as "opt-out" testing.
At present, federal law prohibits the VA system from adopting the CDC's HIV testing recommendations (Department of Veterans Affairs Information, 2006) . However, a number of facility-level efforts are underway to improve HIV testing rates in the VA system. Various approaches include social marketing to encourage providers to prioritize HIV testing, streamlined pretest and posttest counseling, and clinical reminders embedded in the electronic medical record prompting providers to offer HIV testing in the face of documented risk factors (e.g., hepatitis B or C infection, a history of substance abuse, a history of other sexually transmitted diseases, etc.) (Anaya & Asch, 2006; Goetz et al, 2006) . One recent analysis conducted in two VA clinics in a large urban area found that nurse-initiated screening with streamlined counseling and rapid HIV testing was able to double testing rates compared with traditional methods (89% vs. 40%, p < .01) (Anaya et al., 2007) . Although these interventions have demonstrated substantial success at a facility level, system-wide, the majority of VA inpatients and outpatients are not being routinely tested for HIV-as demonstrated by the results of this survey. Therefore, promoting routine HIV testing among veteran patients in support of early diagnosis may require more widespread structural and policy changes.
